Publications by authors named "Maxime Borgeaud"

Claim this Profile
E
Erratum to 'Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review' [Journal of Thoracic Oncology Volume 19 Issue 7 (2024) 973-983].
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, Floryane Kim, Timothée Olivier

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Case Report: Trametinib in the treatment of patients with metastatic lung adenocarcinoma harboring mutation: a case series and literature review.
Floryane Kim, Maxime Borgeaud, Claudio De Vito, Petros Tsantoulis, Alfredo Addeo

Front Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized care for patients with EGFR-mutant nonsmall cell lung cancer: Navigating early to advanced disease management.
Maxime Borgeaud, Timothée Olivier, Jair Bar, Stephanie Pei Li Saw, Kaushal Parikh

CA Cancer J Clin· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Estrogens determine the efficacy of cancer immunotherapy in obese males with melanoma.
Eloïse Dupuychaffray, Hélène Poinot, Aurélie Vuilleumier, Maxime Borgeaud, Montserrat Alvarez

JCI Insight· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Decoding the Clinical and Molecular Signatures of EGFR Common, Compound, and Uncommon Mutations in NSCLC: A Brief Report.
Daniele Tavernari, Maxime Borgeaud, Ximeng Liu, Kaushal Parikh, Xiuning Le

J Thorac Oncol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary and Acquired Resistance to Immunotherapy with Checkpoint Inhibitors in NSCLC: From Bedside to Bench and Back.
Annapaola Mariniello, Maxime Borgeaud, Marc Weiner, Daniele Frisone, Floryane Kim

BioDrugs· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates of febrile neutropenia and its causes in the real world.
Maxime Borgeaud, Simona Perano, Alfredo Addeo, Petros Tsantoulis

Future Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review.
Maxime Borgeaud, Kaushal Parikh, Giuseppe Luigi Banna, Floryane Kim, Timothée Olivier

J Thorac Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of stage III non-small-cell lung cancer: rays of hope.
Floryane Kim, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender

Explor Target Antitumor Ther· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel targets for immune-checkpoint inhibition in cancer.
Maxime Borgeaud, Jose Sandoval, Michel Obeid, Giuseppe Banna, Olivier Michielin

Cancer Treat Rev· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bringing immune-checkpoint inhibitors earlier in the management of non-small cell lung cancer.
Maxime Borgeaud, Alex Friedlaender, Alfredo Addeo

Transl Lung Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy in Urological, Gynecological and Gastrointestinal Cancers - Current Landscape.
Maxime Borgeaud, Marie-Gabrielle Courtes, Petros Tsantoulis, Alexandre Bodmer, Intidhar Labidi-Galy

Praxis (Bern 1994)· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Evolving Role of Immune-Checkpoint Inhibitors in Malignant Pleural Mesothelioma.
Maxime Borgeaud, Floryane Kim, Alex Friedlaender, Filippo Lococo, Alfredo Addeo

J Clin Med· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oncogenic driver mutations in non-small cell lung cancer: Past, present and future.
Mathieu Chevallier, Maxime Borgeaud, Alfredo Addeo, Alex Friedlaender

World J Clin Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Iron deficiency : a new target in treating chronic heart failure ?].
Maxime Borgeaud, Arnaud Perrier

Rev Med Suisse· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis